www.mercurynews.com
1 month agoMedicine
High price of popular diabetes drugs deprives low-income people of effective treatment
Supply shortages and insurance hurdles for GLP-1 agonists due to high drug prices lead to affordability issues for patients with diabetes and obesity. [ more ]